Product Information

ERYTHROMYCIN 250 MG TABLET is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $1.9891 per EA under NDC 70710104703. Its NADAC has been published 166 times since Sep 13, 2023.

FDA first approved this application on Mar 7, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ERYTHROMYCIN 250 MG TABLET

Erythromycin
$1.9891per EA

Strength

250 mg/1

NDC

70710104703

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

ERYTHROMYCIN

Approval Type

Generic (ANDA)

FDA Application

ANDA212693

FDA Approved

3/7/2023

TE Code

AB

On Market Since

6/30/2023

Pharmacological Classes

Decreased Sebaceous Gland Activity
Macrolide Antimicrobial
Macrolide
Macrolides

Price Statistics

The NADAC for ERYTHROMYCIN 250 MG TABLET has been published 166 times since Sep 13, 2023, and over the history we have for it it has declined 59.5%. The table below summarizes its recorded NADAC range and movement.

Current price$1.9891 per EA
All-time high$6.9444 (Oct 11, 2023)
All-time low$1.3349 (May 22, 2024)
52-week high$1.9891
52-week low$1.3571
Median price$1.8424
Average price$2.1781
Largest weekly change-54.7% (Apr 17, 2024)
Weeks tracked166
Tracking sinceSep 13, 2023

Price History

1W

0.0%

1M

+1.7%

3M

+11.1%

6M

+34.5%

1Y

+20.0%

3Y

-42.6%

5Y

N/A

All

-59.5%

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 6% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of ERYTHROMYCIN 250 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ERYTHROMYCIN 250 MG TABLET, manufactured by Zydus Pharmaceuticals (USA) Inc., is $1.9891 per EA (NDC 70710104703), effective Nov 11, 2026.

How has the price of ERYTHROMYCIN 250 MG TABLET changed over time?

Over the history we have for it, the NADAC for ERYTHROMYCIN 250 MG TABLET has declined 59.5%. It has been tracked across 166 weekly CMS publications since Sep 13, 2023.

What are the highest and lowest recorded NADAC prices for ERYTHROMYCIN 250 MG TABLET?

Since Sep 13, 2023, the NADAC for ERYTHROMYCIN 250 MG TABLET has ranged from a low of $1.3349 (May 22, 2024) to a high of $6.9444 (Oct 11, 2023), with a median of $1.8424 per EA.

Are there cheaper alternatives to ERYTHROMYCIN 250 MG TABLET?

Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ERYTHROMYCIN DR 250 MG TABLET, is $1.8786 per EA — about 6% below ERYTHROMYCIN 250 MG TABLET.

Who manufactures ERYTHROMYCIN 250 MG TABLET?

ERYTHROMYCIN 250 MG TABLET (NDC 70710104703) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.